Literature DB >> 26922960

[Non-speech oral motor treatment efficacy for children with developmental speech sound disorders].

A Ygual-Fernandez1, J F Cervera-Merida2.   

Abstract

INTRODUCTION: In the treatment of speech disorders by means of speech therapy two antagonistic methodological approaches are applied: non-verbal ones, based on oral motor exercises (OME), and verbal ones, which are based on speech processing tasks with syllables, phonemes and words. In Spain, OME programmes are called 'programas de praxias', and are widely used and valued by speech therapists. AIM: To review the studies conducted on the effectiveness of OME-based treatments applied to children with speech disorders and the theoretical arguments that could justify, or not, their usefulness. DEVELOPMENT: Over the last few decades evidence has been gathered about the lack of efficacy of this approach to treat developmental speech disorders and pronunciation problems in populations without any neurological alteration of motor functioning. The American Speech-Language-Hearing Association has advised against its use taking into account the principles of evidence-based practice. The knowledge gathered to date on motor control shows that the pattern of mobility and its corresponding organisation in the brain are different in speech and other non-verbal functions linked to nutrition and breathing.
CONCLUSIONS: Neither the studies on their effectiveness nor the arguments based on motor control studies recommend the use of OME-based programmes for the treatment of pronunciation problems in children with developmental language disorders.

Entities:  

Mesh:

Year:  2016        PMID: 26922960

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  1 in total

1.  Nonverbal Oro-Motor Exercises: Do They Really Work for Phonoarticulatory Difficulties?

Authors:  Pablo Parra-López; Marina Olmos-Soria; Ana V Valero-García
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.